Fusion Pharmaceuticals Inc. Deferred Tax Liabilities, Net
Fusion Pharmaceuticals Inc. had Deferred Tax Liabilities, Net of $4.75 million as of 2023-12-31, per its 10-K filed 2024-03-20.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net
us-gaap:DeferredTaxLiabilities · last filed 2024-03-20
- 2023-12-31: Deferred Tax Liabilities, Net $4.75M.
- 2022-12-31: Deferred Tax Liabilities, Net $1.38M.
- 2021-12-31: Deferred Tax Liabilities, Net $1.58M.
- 2020-12-31: Deferred Tax Liabilities, Net $209.00K.
| Period end | Deferred Tax Liabilities, Net |
|---|---|
| 2023-12-31 | $4.75M 10-K · filed 2024-03-20 |
| 2022-12-31 | $1.38M 10-K · filed 2024-03-20 |
| 2021-12-31 | $1.58M 10-K · filed 2023-03-16 |
| 2020-12-31 | $209.00K 10-K · filed 2022-03-17 |